Primary Site >> Biliary tract Cancer
Gene >> CDK4
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
|
Ref: Inhibitory effect of epigallocatechin-3-gallate on growth and invasion in human biliary tract carcinoma cells. PMID: 12053219 Ref: Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma. PMID: 12210082 |
Ref: Intrahepatic cholangiocarcinoma escapes from growth inhibitory effect of transforming growth factor-beta1 by overexpression of cyclin D1. PMID: 15696189 |
Ref: Alterations of gene expression of RB pathway in Opisthorchis viverrini infection-induced cholangiocarcinoma. PMID: 19582476 |
Ref: The risk factor of gallbladder cancer: hyperplasia of mucous epithelium caused by gallstones associates with p16/CyclinD1/CDK4 pathway. PMID: 21777578 |
Ref: Lobaplatin induces apoptosis and arrests cell cycle progression in human cholangiocarcinoma cell line RBE. PMID: 22425181 |
Ref: Involvement of PSMD10, CDK4, and Tumor Suppressors in Development of Intrahepatic Cholangiocarcinoma of Syrian Golden Hamsters Induced by Clonorchis sinensis and N-Nitrosodimethylamine. PMID: 26313366 |
Ref: Comprehensive genomic profiling of extrahepatic cholangiocarcinoma reveals a long tail of therapeutic targets. PMID: 26500333 Ref: [Artemisinin inhibits proliferation of gallbladder cancer cell lines through triggering cell cycle arrest and apoptosis]. PMID: 26932893 Ref: Artemisinin inhibits gallbladder cancer cell lines through triggering cell cycle arrest and apoptosis. PMID: 27035431 |
Ref: Long Noncoding RNA MNX1-AS1 Knockdown Inhibits Cell Proliferation and Migration in Ovarian Cancer. PMID: 28414551 |
Ref: Aspartate beta-hydroxylase promotes cholangiocarcinoma progression by modulating RB1 phosphorylation. PMID: 29733964 Ref: Combined CDK4/6 and pan-mTOR inhibition is synergistic against intrahepatic cholangiocarcinoma. PMID: 30084835 |